1. Neoadjuvant FOLFIRINOX treatment for borderline resectable pancreatic ductal adenocarcinoma: The pathological implications. (April 2016) Authors: Graham, J.; Jamieson, N.; Duthie, F.; Palani Velu, L.; Ali, C.; Maclaren, V.; Grose, D.; Mcintosh, D.; Mckay, C.J.; Dickson, E.; Carter, R. Journal: HPB Issue: Volume 18(2016)Supplement 1 Page Start: e5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗